346 related articles for article (PubMed ID: 18322260)
1. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
Adams RJ; Albers G; Alberts MJ; Benavente O; Furie K; Goldstein LB; Gorelick P; Halperin J; Harbaugh R; Johnston SC; Katzan I; Kelly-Hayes M; Kenton EJ; Marks M; Sacco RL; Schwamm LH; ;
Stroke; 2008 May; 39(5):1647-52. PubMed ID: 18322260
[No Abstract] [Full Text] [Related]
2. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
Overgaard K; Poulsen TS; Husted SE
Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
[TBL] [Abstract][Full Text] [Related]
3. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
4. [Secondary prevention with clopidogrel after TIA or stroke].
Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB
Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963
[TBL] [Abstract][Full Text] [Related]
5. Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack.
Hills NK; Johnston SC
Stroke; 2008 Apr; 39(4):1228-32. PubMed ID: 18323509
[TBL] [Abstract][Full Text] [Related]
6. Aspirin therapy should be first-line treatment in secondary prevention of stroke--against.
Diener HC
Stroke; 2002 Aug; 33(8):2138-9. PubMed ID: 12154277
[No Abstract] [Full Text] [Related]
7. Antiplatelet therapy for transient ischemic attack.
Acelajado MC; Oparil S
J Clin Hypertens (Greenwich); 2012 Feb; 14(2):103-111. PubMed ID: 22277143
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
9. Update on antiplatelet agents, including MATCH, CHARISMA, and ESPRIT.
Skliut M; Jamieson DG
Curr Cardiol Rep; 2008 Feb; 10(1):9-16. PubMed ID: 18416995
[TBL] [Abstract][Full Text] [Related]
10. Adding aspirin to clopidogrel after TIA and ischemic stroke: benefits do not match risks.
Hankey GJ; Eikelboom JW
Neurology; 2005 Apr; 64(7):1117-21. PubMed ID: 15824331
[TBL] [Abstract][Full Text] [Related]
11. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
Simmons BB; Yeo A; Fung K; ;
Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
14. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
Wang Y; Chen W; Wang Y
Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
[TBL] [Abstract][Full Text] [Related]
15. Secondary prevention of ischaemic stroke and TIA.
Diener HC
Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
[No Abstract] [Full Text] [Related]
16. Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Lalouschek W; Lang W; Müllner M;
Stroke; 2001 Dec; 32(12):2860-6. PubMed ID: 11739988
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombotic treatment as primary and secondary prevention of stroke].
Chukanova EI; Chukanova AS; Nadareyshvili GG; Gulieva MS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):85-88. PubMed ID: 28635860
[TBL] [Abstract][Full Text] [Related]
18. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient: a neurologist's view.
Gebel JM
J Am Coll Cardiol; 2005 Sep; 46(5):752-5. PubMed ID: 16139120
[TBL] [Abstract][Full Text] [Related]
19. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials.
Hankey GJ; Sudlow CL; Dunbabin DW
Stroke; 2000 Jul; 31(7):1779-84. PubMed ID: 10884487
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelets in secondary stroke prevention: should clopidogrel be the first choice?
Aw D; Sharma JC
Postgrad Med J; 2012 Jan; 88(1035):34-7. PubMed ID: 22121248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]